Articles From: Tech Firms Buy Up Property for Future Growth to Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. Stockholders


2015/3/3
By Eliot Brown Some of Silicon Valley's biggest companies are on a real estate buying binge, paying premium prices to make sure they have enough space for future expansion.
Sign-up for Tech Firms Buy Up Property for Future Growth investment picks
2015/2/10
By Eliot Brown When landlord Monday Properties broke ground in 2010 on the Washington-area's now-tallest building, the move appeared savvy.
Sign-up for Washington, D.C. Area's Tallest Office Building Sits Without Tenant investment picks
2015/2/9
Audible, Inc., the world’s largest seller and producer of downloadable audiobooks and other spoken-word content, today announced the release of Classic Love Poems , a collection of 15 of the canon’s most enduring romantic verse, brilliantly performed by The Hobbit actor Richard Armitage.
Sign-up for Richard Armitage’s Performance of Classic Love Poems Now Available as a Free Audio Download at Audible.com investment picks
2015/2/18
By Elizabeth Dwoskin and Thomas Gryta For $70 a month, you can enjoy AT&T Inc. 's ultrafast fiber-optic Internet access.
Sign-up for AT&T tacks a privacy charge on high speed investment picks
2015/1/14
By Elizabeth Dwoskin Data analytics company MongoDB is now valued by venture capitalists at $1.6 billion after raising new funding, according to a person familiar with the matter.
Sign-up for Big-data startup MongoDB now valued at $1.6 billion investment picks
2015/1/10
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/1/8
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/1/20
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/1/17
By Elizabeth O'Brien, MarketWatch They say the best exercise program is any one that you can stick with.
Sign-up for UPDATE: 3 health resolutions you can actually keep in 2015 investment picks
2015/2/5
By Elizabeth O'Brien, MarketWatch What you need to know, and do, before Feb.
Sign-up for UPDATE: How to beat this month's Obamacare deadline investment picks
2015/2/26
By Ellen Emmerentze Jervell BONN, Germany--
Sign-up for Deutsche Telekom Helped by U.S. investment picks
2015/2/10
By Ellen Emmerentze Jervell DÜSSELDORF - Metro AG (MEO.XE) Tuesday said its first fiscal quarter profit fell, due to negative currency effects.
Sign-up for Metro 1Q Earnings Fall, Hurt By Foreign Exchange Losses investment picks
2015/2/10
By Ellen Emmerentze Jervell DÜSSELDORF--
Sign-up for Germany's Metro Rocked by Ruble -- Update investment picks
2015/2/2
By Ellen Emmerentze Jervell FRANKFURT--Adidas AG said on Monday that it achieved record sales in Germany, Austria and Switzerland during 2014.
Sign-up for Adidas Sees Record Sales in Germany, Austria and Switzerland in 2014 investment picks
2015/2/26
By Ellen Emmerentze Jervell FRANKFURT--Deutsche Telekom AG (DTE.XE) said Thursday that it narrowed its net loss in the fourth quarter, thanks to a strong U.S. performance and stable growth in Germany.
Sign-up for Deutsche Telekom Loss Narrowed by Strong U.S. investment picks
2015/2/16
By Ellen Emmerentze Jervell HERZOGENAURACH, Germany--Puma SE almost broke even in the fourth quarter on improved sales of its sports shoes and other apparel as well as lower costs, with the German company confident a full financial turnaround is under way.
Sign-up for Puma Net Loss Narrows, Management Upbeat--Update investment picks
2015/2/16
By Ellen Emmerentze Jervell HERZOGENAURACH, Germany--Puma SE almost broke even in the fourth quarter on improved sales of its sports shoes and other apparel as well as lower costs, with the German company confident a full financial turnaround is under way.
Sign-up for Puma Net Loss Narrows, Management Upbeat investment picks
2015/1/12
Kirby McInerney LLP is investigating potential claims against NPS Pharmaceuticals, Inc. (“NPS” or the “Company”) (NASDAQ:NPSP) concerning the proposed acquisition of the Company by Shire plc (“Shire”) (LSE: SHP) (NASDAQ: SHPG). Under the terms of the merger agreement, NPS stockholders will receive $46.00 in cash for each share of NPS common stock they own, valuing the transaction at approximately $5.2 billion.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NPS Pharmaceuticals, Inc. Stockholders investment picks
2015/1/6
Kirby McInerney LLP is investigating potential claims against the Board of Directors of MiMedx Group, Inc. (“MiMedx” or the “Company”) (Nasdaq:MDXG) concerning the government investigation into the Company’s sales and marketing activities.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of MiMedx Group, Inc. Stockholders investment picks
2015/1/6
Kirby McInerney LLP is investigating potential claims against Uranerz Energy Corporation (“Uranerz” or the “Company”) (NYSE: URZ) (TSX: URZ) concerning the proposed acquisition of the Company by Energy Fuels Inc. (“Energy Fuels”) (NYSE: UUUU) (TSX: EFR). Under the terms of the definitive agreement, Uranerz stockholders will receive 0.255 common shares of Energy Fuels for each share of Uranerz common stock they own, valuing the deal at approximately $1.57 per share.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Uranerz Energy Corporation Stockholders investment picks
2014/12/18
Kirby McInerney LLP is investigating potential claims against The Pantry, Inc. (“Pantry” or the “Company”) (NASDAQ:PTRY) concerning the proposed acquisition of the Company by Alimentation Couche-Tard Inc. (“Couche-Tard”) (TSX:ATD.A) (TSX:ATD.B). Under the terms of the definitive merger agreement, Pantry stockholders will receive $36.75 in cash for each share of Pantry common stock they own, valuing the transaction at approximately $1.7 billion including the assumption of debt.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of The Pantry, Inc. Stockholders investment picks
2014/12/16
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Medifast, Inc. (“Medifast” or the “Company”) (NYSE:MED) concerning the improper compensation of the Company’s executives.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Medifast, Inc. Stockholders investment picks
2014/12/16
Kirby McInerney LLP is investigating potential claims against PetSmart, Inc. (“PetSmart” or the “Company”) (NASDAQ:PETM) concerning the proposed acquisition of the Company by a consortium led by BC Partners, Inc (“BC Partners”). The consortium includes Funds advised by BC Partners (“the BC Funds”), alongside several of its limited partners, including La Caisse de dépôt et placement du Québec (“La Caisse”) and StepStone.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of PetSmart, Inc. Stockholders investment picks
2015/2/3
Kirby McInerney LLP is investigating potential claims against Advent Software, Inc. (“Advent” or the “Company”) (NASDAQ:ADVS) concerning the proposed acquisition of the Company by SS&C Technologies Holdings, Inc. (“SS&C”) (NASDAQ:SSNC). Under the terms of the definitive agreement, Advent stockholders will receive $44.25 in cash for each share of Advent common stock they own.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Advent Software, Inc. Stockholders investment picks
2015/2/6
Kirby McInerney LLP is investigating potential claims against E2open, Inc. (“E2open” or the “Company”) (NASDAQ:EOPN) concerning the proposed acquisition of the Company by Insight Venture Partners (“Insight”). Under the terms of the definitive merger agreement, E2open stockholders will receive $8.60 in cash for each share of E2open common stock they own, valuing the transaction at approximately $273 million.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of E2open, Inc. Stockholders investment picks
2015/2/4
Kirby McInerney LLP is investigating potential claims against Office Depot, Inc. (“Office Depot” or the “Company”) (NASDAQ:ODP) concerning the proposed acquisition of the Company by Staples, Inc. (“Staples”) (NASDAQ:SPLS). Under the terms of the definitive agreement, Office Depot stockholders will receive $7.25 in cash and 0.2188 shares of Staples common stock for each share of Office Depot common stock they own, valuing the deal at approximately $11.00 per share.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Office Depot, Inc. Stockholders investment picks
2015/2/5
Kirby McInerney LLP is investigating potential claims against Hospira, Inc. (“Hospira” or the “Company”) (NYSE:HSP) concerning the proposed acquisition of the Company by Pfizer Inc. (“Pfizer”) (NYSE:PFE). Under the terms of the definitive merger agreement, Hospira stockholders will receive $90.00 in cash for each share of Hospira common stock they own, valuing the transaction at a total enterprise value of approximately $17 billion.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hospira, Inc. Stockholders investment picks
2015/2/23
Kirby McInerney LLP is investigating potential claims against Polypore International, Inc. (“Polypore” or the “Company”) (NYSE:PPO) concerning the proposed acquisition of the Company by Asahi Kasei Corporation (“Asahi”). Under the terms of the proposed transaction, Polypore stockholders will receive $60.50 in cash for each share of Polypore common stock they own.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Polypore International, Inc. Stockholders investment picks
2015/2/18
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Hyperion Therapeutics, Inc. (“Hyperion” or the “Company”) (NASDAQ:HPTX) concerning the termination of the development of its Type 1 diabetes drug due to the manipulation of trial data.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hyperion Therapeutics, Inc. Stockholders investment picks
2015/2/17
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Teva Pharmaceutical Industries Ltd.
Sign-up for Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. Stockholders investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Tech Firms Buy Up Property for Future Growth to Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. Stockholders
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent